Effect of Electrical Current on the Activities of Antimicrobial Agents against Pseudomonas aeruginosa , Staphylococcus aureus , and Staphylococcus epidermidis Biofilms

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

Bacterial biofilms are resistant to conventional antimicrobial agents. Prior in vitro studies have shown that electrical current (EC) enhances the activities of aminoglycosides, quinolones, and oxytetracycline against Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus epidermidis, Escherichia coli, and Streptococcus gordonii. This phenomenon, known as the bioelectric effect, has been only partially defined. The purpose of this work was to study the in vitro bioelectric effect on the activities of 11 antimicrobial agents representing a variety of different classes against P. aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and S. epidermidis. An eight-channel current generator/controller and eight chambers delivering a continuous flow of fresh medium with or without antimicrobial agents and/or EC to biofilm-coated coupons were used. No significant decreases in the numbers of log(10) CFU/cm(2) were seen after exposure to antimicrobial agents alone, with the exception of a 4.57-log-unit reduction for S. epidermidis and trimethoprim-sulfamethoxazole. We detected a statistically significant bioelectric effect when vancomycin plus 2,000 microamperes EC were used against MRSA biofilms (P = 0.04) and when daptomycin and erythromycin were used in combination with 200 or 2,000 microamperes EC against S. epidermidis biofilms (P = 0.02 and 0.0004, respectively). The results of these experiments indicate that the enhancement of the activity of antimicrobial agents against biofilm organisms by EC is not a generalizable phenomenon across microorganisms and antimicrobial agents.

Knowledge Graph

Similar Paper

Effect of Electrical Current on the Activities of Antimicrobial Agents against Pseudomonas aeruginosa , Staphylococcus aureus , and Staphylococcus epidermidis Biofilms
Antimicrobial Agents and Chemotherapy 2009.0
Comparison of the Antimicrobial Effects of Chlorine, Silver Ion, and Tobramycin on Biofilm
Antimicrobial Agents and Chemotherapy 2008.0
Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a NovelIn VitroModel ofStaphylococcus aureusBiofilm
Antimicrobial Agents and Chemotherapy 2010.0
Activity of lipo-cyclic γ-AApeptides against biofilms of Staphylococcus epidermidis and Pseudomonas aeruginosa
Bioorganic & Medicinal Chemistry Letters 2015.0
Asiatic Acid and Corosolic Acid Enhance the Susceptibility of Pseudomonas aeruginosa Biofilms to Tobramycin
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro Activities of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus , S . epidermidis , and Enterococcus faecalis Strains
Antimicrobial Agents and Chemotherapy 2009.0
Synergy between Polyethylenimine and Different Families of Antibiotics against a Resistant Clinical Isolate of Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2008.0
In Vitro Effects of Antimicrobial Agents on Planktonic and Biofilm Forms of Staphylococcus lugdunensis Clinical Isolates
Antimicrobial Agents and Chemotherapy 2007.0
Increased Temperature Enhances the Antimicrobial Effects of Daptomycin, Vancomycin, Tigecycline, Fosfomycin, and Cefamandole on Staphylococcal Biofilms
Antimicrobial Agents and Chemotherapy 2010.0
Novel Potentiators for Vancomycin in the Treatment of Biofilm-Related MRSA Infections via a Mix and Match Approach
ACS Medicinal Chemistry Letters 2017.0